company background image
4886 logo

ASKA Pharmaceutical HoldingsLtd TSE:4886 Stock Report

Last Price

JP¥2.38k

Market Cap

JP¥67.3b

7D

-1.0%

1Y

61.3%

Updated

17 Jul, 2024

Data

Company Financials +

ASKA Pharmaceutical Holdings Co.,Ltd.

TSE:4886 Stock Report

Market Cap: JP¥67.3b

ASKA Pharmaceutical Holdings Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ASKA Pharmaceutical HoldingsLtd
Historical stock prices
Current Share PriceJP¥2,375.00
52 Week HighJP¥2,720.00
52 Week LowJP¥1,447.00
Beta0.53
11 Month Change-1.00%
3 Month Change5.46%
1 Year Change61.35%
33 Year Change142.10%
5 Year Change86.42%
Change since IPO13.10%

Recent News & Updates

ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Solid Profits Have Weak Fundamentals

May 21
ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Solid Profits Have Weak Fundamentals

Recent updates

ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Solid Profits Have Weak Fundamentals

May 21
ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Solid Profits Have Weak Fundamentals

Shareholder Returns

4886JP PharmaceuticalsJP Market
7D-1.0%0.2%0.3%
1Y61.3%21.1%25.7%

Return vs Industry: 4886 exceeded the JP Pharmaceuticals industry which returned 21.1% over the past year.

Return vs Market: 4886 exceeded the JP Market which returned 25.7% over the past year.

Price Volatility

Is 4886's price volatile compared to industry and market?
4886 volatility
4886 Average Weekly Movement7.1%
Pharmaceuticals Industry Average Movement3.9%
Market Average Movement3.8%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 4886 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4886's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

FoundedEmployeesCEOWebsite
1920762Takashi Yamaguchiwww.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices.

ASKA Pharmaceutical Holdings Co.,Ltd. Fundamentals Summary

How do ASKA Pharmaceutical HoldingsLtd's earnings and revenue compare to its market cap?
4886 fundamental statistics
Market capJP¥67.28b
Earnings (TTM)JP¥7.55b
Revenue (TTM)JP¥62.84b

8.9x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4886 income statement (TTM)
RevenueJP¥62.84b
Cost of RevenueJP¥32.18b
Gross ProfitJP¥30.67b
Other ExpensesJP¥23.12b
EarningsJP¥7.55b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 05, 2024

Earnings per share (EPS)266.33
Gross Margin48.80%
Net Profit Margin12.01%
Debt/Equity Ratio15.3%

How did 4886 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

12%

Payout Ratio

Does 4886 pay a reliable dividends?

See 4886 dividend history and benchmarks
When do you need to buy 4886 by to receive an upcoming dividend?
ASKA Pharmaceutical HoldingsLtd dividend dates
Ex Dividend DateSep 27 2024
Dividend Pay DateDec 02 2024
Days until Ex dividend71 days
Days until Dividend pay date137 days

Does 4886 pay a reliable dividends?

See 4886 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.